EFTUD2 Antibody

Immunoprecipitation: EFTUD2 Antibody [NB100-40849]

Immunoprecipitation: EFTUD2 Antibody [NB100-40849] - Whole cell lysate from HeLa (5, 15 and 50 ug for WB; 1 mg for IP, 20% of IP loaded), 293T (T; 50 ug) and mouse NIH3T3 (M; 50 ug) cells. Affinity purified rabbit anti- EFTUD2/SNRP116 antibody 0.04 ug/ml (A) and 0.1 ug/ml (B) and used for IP at 3 ug/mg lysate (B).

Western Blot: EFTUD2 Antibody [NB100-40849] -

Western Blot: EFTUD2 Antibody [NB100-40849] - EFTUD2 expression is necessary for HCC cell survival.a The protein & mRNA levels of EFTUD2 expression in HCC cells detected by western blot & qPCR. b Western blot analysis of EFTUD2 expression in Hep3B & Huh7 cells infected with siRNA against EFTUD2 (siEFTUD2). c. d The effect of EFTUD2 on cellular viability was detected by CCK8 assays & colony formation assays, respectively. e Western blot analysis of EFTUD2 protein expression in Hep3B & Huh7 cells infected with lentiviruses expressing either scrambled shRNA or shRNA against EFTUD2 (shEFTUD2). f Representative images show the cell morphological changes after the stable knockdown of EFTUD2. Scale bars, 100 μm. g, h CCK8 assays & colony formation assays show the effect of EFTUD2 on cellular survival in Hep3B & Huh7 cells with a stable knockdown of EFTUD2. The data are presented as means ± SD. *P < 0.05; **P < 0.01; ***P < 0.001. Image collected & cropped by CiteAb from the following publication (https://pubmed.ncbi.nlm.nih.gov/33024090), licensed under a CC-BY license. Not internally tested by Novus Biologicals.

Western Blot: EFTUD2 Antibody [NB100-40849] -

Western Blot: EFTUD2 Antibody [NB100-40849] - EFTUD2 promotes EMT via activation of the STAT3 pathway in HCC cells.a An M–A plot showed the genes differentially expressed between EFTUD2-overexpressing & control Hep G2 cells (N = 3), with the differentially regulated genes highlighted in red. b Gene sets of the IL6_JAK_STAT3 signaling pathway & the EMT were enriched in EFTUD2-overexpressing Hep G2 cells. c Serial sections of the xenograft tumors were subjected to IHC staining of EFTUD2, pSTAT3, E-cadherin & vimentin. Scale bars, 100 μm. d Serial sections of human HCC tissue samples were subjected to IHC staining with antibodies against EFTUD2 & pSTAT3. Representative IHC images were showed in the left panel, & the right panel showed the correlation between EFTUD2 & pSTAT3 expression, in 50 human HCC tissue samples. Scale bars, 100 μm. e The expression of EFTUD2, vimentin, Twist1, E-cadherin, STAT3, pSTAT3, MCL-1, & GAPDH was detected by western blotting in the indicated cells. f Western blot analysis showing that the increases in pSTAT3 & vimentin expression were compromised & that the decrease in E-cadherin was reversed by SI3-201, a STAT3 inhibitor, in EFTUD2-overexpressing Hep G2 cells. g The Hep G2 cells with EFTUD2 overexpression were treated with 100 μM SI3-201 & subjected to migration & invasion assays. Scale bars, 200 μm. The data are presented as the mean ± SD from triplicate independent experiments, **P < 0.01. Image collected & cropped by CiteAb from the following publication (https://pubmed.ncbi.nlm.nih.gov/33024090), licensed under a CC-BY license. Not internally tested by Novus Biologicals.

Western Blot: EFTUD2 Antibody [NB100-40849] -

Western Blot: EFTUD2 Antibody [NB100-40849] - EFTUD2 promotes EMT via activation of the STAT3 pathway in HCC cells.a An M–A plot showed the genes differentially expressed between EFTUD2-overexpressing & control Hep G2 cells (N = 3), with the differentially regulated genes highlighted in red. b Gene sets of the IL6_JAK_STAT3 signaling pathway & the EMT were enriched in EFTUD2-overexpressing Hep G2 cells. c Serial sections of the xenograft tumors were subjected to IHC staining of EFTUD2, pSTAT3, E-cadherin & vimentin. Scale bars, 100 μm. d Serial sections of human HCC tissue samples were subjected to IHC staining with antibodies against EFTUD2 & pSTAT3. Representative IHC images were showed in the left panel, & the right panel showed the correlation between EFTUD2 & pSTAT3 expression, in 50 human HCC tissue samples. Scale bars, 100 μm. e The expression of EFTUD2, vimentin, Twist1, E-cadherin, STAT3, pSTAT3, MCL-1, & GAPDH was detected by western blotting in the indicated cells. f Western blot analysis showing that the increases in pSTAT3 & vimentin expression were compromised & that the decrease in E-cadherin was reversed by SI3-201, a STAT3 inhibitor, in EFTUD2-overexpressing Hep G2 cells. g The Hep G2 cells with EFTUD2 overexpression were treated with 100 μM SI3-201 & subjected to migration & invasion assays. Scale bars, 200 μm. The data are presented as the mean ± SD from triplicate independent experiments, **P < 0.01. Image collected & cropped by CiteAb from the following publication (https://pubmed.ncbi.nlm.nih.gov/33024090), licensed under a CC-BY license. Not internally tested by Novus Biologicals.

Western Blot: EFTUD2 Antibody [NB100-40849] -

Western Blot: EFTUD2 Antibody [NB100-40849] - Depletion of EFTUD2 blocks cell cycle progression & promotes cell apoptosis.a EdU incorporation assays were used to identify the cells in S phase after EFTUD2 silencing in the indicated cells. Red: cell in S phase. Scale bars, 200 μm. b The cell cycle analyses were performed in Hep3B & Huh7 cells with EFTUD2 knockdown. c, d Fluorescence microscopy & flow cytometry were performed to captured early apoptotic cells by mitochondrial membrane potential changes in Hep3B & Huh7 cells with EFTUD2 knockdown. Red, JC-1 aggregates; green, JC-1 monomers. Scale bars, 10 μm. e, f EFTUD2-silenced Hep3B & Huh7 cells treated with or without CDDP (2 μg/mL; 48 h) were stained with a combination of Annexin V-FITC & PI & analyzed by FACS. Cells positive for FITC staining were counted as apoptotic cells. The bar graphs show the percentage of apoptotic cells. g Apoptosis-associated proteins of the indicated cells were measured by western blotting. The data are presented as the means ± SD. *P < 0.05; **P < 0.01; ***P < 0.001. Image collected & cropped by CiteAb from the following publication (https://pubmed.ncbi.nlm.nih.gov/33024090), licensed under a CC-BY license. Not internally tested by Novus Biologicals.

Western Blot: EFTUD2 Antibody [NB100-40849] -

Western Blot: EFTUD2 Antibody [NB100-40849] - EFTUD2 promotes HCC growth.a Western blot analysis of EFTUD2 protein expression in Hep G2 cells infected with the EFTUD2 overexpression lentivirus or the vector lentivirus. b, c The effect of EFTUD2 overexpression on cell proliferation was detected by CCK8 assays & colony formation assays. d EdU incorporation assays were used to identify the cells in S phase. e The distribution of different cell cycle phases in the indicated cells. f Tumor volumes were measured & recorded every 3 days, & a growth curve was plotted. g Subcutaneous xenograft tumors of the indicated cells. The right panel shows the wet weights of the xenograft tumors. h Representative images of H&E & IHC staining of EFTUD2 & Ki67 in the xenograft tumors. Scale bars, 100 μm. The data are presented as the means ± SD. *P < 0.05; **P < 0.01; ***P < 0.001; NS no significance. Image collected & cropped by CiteAb from the following publication (https://pubmed.ncbi.nlm.nih.gov/33024090), licensed under a CC-BY license. Not internally tested by Novus Biologicals.